Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Eur J Cancer Prev. 2019 Nov;28(6):483–491. doi: 10.1097/CEJ.0000000000000505

Figure 7. Tumor free survival in K14E6/E7 mice.

Figure 7.

K14E6/E7 mice were given no treatment (Control), topical BEZ235 alone (topical BEZ235), DMBA alone (DMBA), or DMBA and topical BEZ235 concurrently (DMBA+ topical BEZ235). Mice were evaluated weekly, then euthanized at 20 weeks. The DMBA+BEZ235 group survived, on average, 19.3 weeks prior to tumor onset, whereas the DMBA alone group survived, on average, 16.9 weeks. This difference in tumor free survival was significant at P < 0.000001.